Cole Schmidtknecht, 22, couldn't pay for his daily inhaler due to the “prohibitively expensive” price increase. Two weeks ...

Shanon and William Schmidtknecht, of Poynette, say their 22-year-old son Cole was told the cost had jumped from $66 to $539 ...

Specifically, Dupixent is approved to treat moderate to severe asthma that is either: dependent on treatment with an oral corticosteroid, or eosinophilic (caused by an increase in eosinophils ...

It's flu season, the number one trigger for asthma exacerbations in children. And now suddenly families can't get the preventive medication ... motivated by what's best for the patients.

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Researchers observed that only 8.3% of 24 children or adolescents with peanut allergy passed a double-blind ...

Ethris announces promising phase 1 results for ETH47, its mRNA therapy for uncontrolled asthma. The inhaled treatment showed ...

If you’re in an urgent situation and need asthma medication to breathe ... team and prescribing doctor can advise you best on specific medications and inhalers and what possible risks or ...

Of four treatment response measures recorded at 6 months of mepolizumab treatment, an Asthma Control Questionnaire score was ...